|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Effect of the intrauterine contraceptive device on protein components of |
| Tauber PF; Cramer GM; Zaneveld LJ |
| CONTRACEPTION. 1993 Nov;48(5):494-512. |
| The albumin, immunoglobulin G (IgG), immunoglobulin A (IgA), lysozyme, lactoferrin, alpha1-antitrypsin, alpha1x- |
| antichymotrypsin, and neutral proteinase levels of uterine fluid and serum of IUD-bearing women were studied in |
| relationship to the phase of the menstrual cycle, the length of IUD implantation, and the presence of reported side |
| effects. Selection of these proteins was based on their potential importance in IUD-induced contraceptive action |
| and/or side effects. Generally, only small differences were found in the serum levels of these proteins during the |
| cycle, with different length of implantation or between patients with and without side effects. However, transudation |
| of proteins (albumin, IgG, alpha1-antitrypsin, alpha1x-antichymotrypsin) from blood into the uterine cavity was |
| enhanced by the IUD, especially during the postmenstrual and premenstrual periods. The IUD enhanced the local |
| secretory response even more, i.e., the increased release of proteins from the endometrium (lysozyme, neutral |
| proteinase, IgA) and from leukocytes (lysozyme, lactoferrin). Protein changes occurred as the period of insertion |
| increased. These changes in the uterine milieu may account in part for the contraceptive action of the IUD. The |
| secretory proteins rather than the transudation products differed between patients who showed IUD-associated side |
| effects vs. those who did not, implying that IUD-related pathology is primarily associated with changes in local |
| secretory response. The possible role of each protein in the mechanism of IUD action is presented in view of the |
| present findings. (PubHealth.info Document ID: CONT2T 4545-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Effect of the intrauterine contraceptive device on protein |
| components of human uterine fluid.", is(are) Tauber PF; Cramer GM; Zaneveld LJ. The source of this article is |
| "CONTRACEPTION. 1993 Nov;48(5):494-512.". This article was published in 1993 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 4545-06. All rights reserved with PubHealth.info) PIN: 9545 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |